Please login to the form below

Not currently logged in
Email:
Password:

Simponi

This page shows the latest Simponi news and features for those working in and with pharma, biotech and healthcare.

Takeda makes Crohn’s disease case for subcutaneous Entyvio

Takeda makes Crohn’s disease case for subcutaneous Entyvio

to compete strongly against well-established ulcerative colitis drugs such as Humira and Johnson &Johnson’s Simponi (golimumab).

Latest news

More from news
Approximately 6 fully matching, plus 30 partially matching documents found.

Latest Intelligence

  • Biosimilars - the same, but different? Biosimilars - the same, but different?

    The two infliximab biosimilars are also included in the cost-effectiveness watchdog's ongoing appraisals of TNF-alpha inhibitors for ankylosing spondylitis and its review of Humira, Enbrel, Remicade, Cimzia, Simponi,

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 4 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Ashfield

Ashfield, part of UDG Healthcare plc, is a global leader in commercialisation services for the healthcare industry. We partner with...

Latest intelligence

Alzheimers
Detecting Alzheimer’s ahead of a cure
A focus on promising new research...
Programmatic methodology and why you should be using it
What is it? How does it work? Why is everyone talking about it? By Richard Webb - Associate Director...
Can you survive without the blue dot?
Or has the digital world has replaced our brain...

Infographics